Beyond Journal Club Podcast from Core IM

Published January 31, 2024

How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group.

02:30 – Epidemiology of RSV
03:46 – Development of RSV vaccine
05:55 – Vaccine trial design
12:22 – ARESVI and RENOIR Trials
18:18 – Who should we recommend the RSV vaccine to?
19:50 – What don’t we know?

Read the Show Notes and learn more about Core IM.

View the episode transcript and references.

Read the NEJM Original Article, Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Review the relevant section on Upper Respiratory Tract Infections in the Pediatric Infectious Diseases guide in Rotation Prep.

Beyond Journal Club is a new collaboration between Core IM and NEJM Group where we put the results of clinical trials into context. We tell the story of how we arrived at the current standard of care, appreciate the clinical question of the trial at hand, and interpret what the findings may mean for this patient population.